The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures – all unavailable elsewhere.
The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Drug Delivery Technologies market forecasts from 2019-2029
• Drug Delivery Technologies submarket forecasts from 2019-2029 covering: • Oral Drug Delivery Technology • Inhalable Drug Delivery Technology • Injectable/Implantable Drug Delivery Technology • Transdermal Drug Delivery Technology • Ocular Drug Delivery Technology • Nasal/Buccal Drug Delivery Technology
This report discusses the drivers and restraints of each submarket.
• Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering: • North America: US, Canada, Mexico • Europe: Germany, France, UK, Italy, Spain, Rest of Europe • Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific • Latin America: Brazil and Rest of Latin America • Rest of the World: Middle East, Africa
• Assessment of the leading companies in the Drug Delivery Technologies market: • 3M • Alkermes PLC • Altea Therapeutics Corporation • Antares Pharma Inc. • Applied Pharma Research S.A. (APR) • Becton, Dickinson & Company • Ethypharm SA • Glycologic Limited • Intercell AG • NanoPass Technologies Ltd. • pSivida
• SWOT analysis of the drug delivery technologies market
Visiongain’s study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.
Buy our report today Drug Delivery Technologies Market : Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Global Drug Delivery Technology Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Drug Delivery Technologies: An Introduction
2.1 Drug Delivery Technologies: Strategies to Improve Existing Drugs
2.2 The Global Drug Delivery Technology Market: Methods of Administration
2.2.1 The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
2.2.2 Sustained/Controlled Release Systems
2.2.3 Oral Drug Delivery: Swallowing Drugs to Reach a Target
2.2.4 Pulmonary Delivery: Delivered by Inhalation
2.2.5 Injection as a Route of Drug Delivery
2.2.6 Transdermal Delivery: More Patient-Friendly
2.2.7 Various Transmucosal Delivery Routes for Delivery
2.2.8 Ocular Delivery: Overcoming Unique Barriers
2.3 Regulation in the US
2.3.1 Regulation of Combination Products
2.3.2 FDA Guidelines for Injectors
2.4 Biopharmaceuticals
2.4.1 An Introduction to the Biological Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biologics with Associated Drug Delivery Technologies
2.4.4 PEGylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. Drug Delivery Technology: Global Market Forecast 2019-2029
3.1 The Global Drug Delivery Technology Market in 2018
3.2 The Global Drug Delivery Technology Market Forecast 2019-2029
3.3 Drug Delivery Technology: Drivers and Restraints 2019-2029
3.4 Biologics: A Driver for Growth in Drug Delivery Technologies
3.4.1 The Global Biological Drugs Market Forecast
3.4.2 Leading Classes of Biological Drugs
3.4.3 Monoclonal Antibodies: Largest Sector in Biologics
3.4.4 Human insulin: Leading the Therapeutic Protein Segment
3.4.5 Interferon Products for the Treatment of Hepatitis
3.5 Vaccines: Meeting the Unmet Needs
3.5.1 The Global Vaccines Market Forecast
4. Drug Delivery Technologies: Submarkets Forecast 2019-2029
4.1 The Global Drug Delivery Technology Market by Submarkets
4.2 How Will Segmental Market Shares Change to 2028?
4.3 Oral Drug Delivery Technology
4.3.1 Oral Drug Delivery Technology Market Forecast 2019-2029
4.3.2 Trends and Developments
4.3.2.1 Delivering APIs to the Colon
4.3.2.2 Google Investing in Robotic Pill
4.3.3 Oral Drug Delivery Technologies: Drivers and Restraints 2019-2029
4.4 Inhalable Drug Delivery Technology
4.4.1 Inhalable Drug Delivery Technology Market Forecast 2019-2029
4.4.2 Trends and Developments
4.4.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms
4.4.2.2 Condensation Aerosol Generated by Heat
4.4.2.3 Is Inhaled Insulin Marketable?
4.4.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2019-2029
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033
The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
